A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
Hoel F ,, et al. (2021) A map of metabolic […]
Hoel F ,, et al. (2021) A map of metabolic […]
Huth TK et al. (2020) A systematic review of metabolomic
Apostolou E et al. (2022) Saliva antibody-fingerprint of reactivated latent
No serological evidence for a role of HHV-6 infection in chronic fatigue syndrome. Read More »
Burbelo PD et al. (2012) No serological evidence for a
Cameron B et al. (2010) Serological and virological investigation of
Chapenko S et al . (2012) Association of active human
Cox BS et al. (2022) EBV/HHV-6A dUTPases contribute to Myalgic
Domingues TD et al. (2021) Herpesviruses Serology Distinguishes Different Subgroups
Fevang B et al. (2021) Lasting Immunological Imprint of Primary
Gravelsina S et al. (2022) Biomarkers in the diagnostic algorithm
Tissue specific signature of HHV-6 infection in ME/CFS. Read More »
Kasimir F, et al. (2022), Tissue specific signature of HHV-6
Kogelnik AM et al. (2006) Use of valganciclovir in patients
Lee JS et al . (2021) Salivary DNA Loads for
Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome. Read More »
Loebel M et al. (2014) Deficient EBV-Specific B- and T-Cell
Maltsev D (2022) A comparative study of valaciclovir, valganciclovir, and
Montoya JG et al. (2013) Randomized clinical trial to evaluate
Peluso MJ et al. (2022) Impact of pre-existing chronic viral
Rasa-Dzelzkaleja S et al. (2023) The persistent viral infections in
Sep�lveda N et al. (2022) Revisiting IgG antibody reactivity to
Schreiner P et al. (2020) Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation,